$0.22 EPS Expected for Horizon Pharma Public Limited Company (HZNP); AMAZING ENERGY OIL &amp GAS CO (AMAZ) Shorts Down By 68.33%

February 21, 2018 - By wolcottdaily

Analysts expect Horizon Pharma Public Limited Company (NASDAQ:HZNP) to report $0.22 EPS on February, 28 before the open.They anticipate $0.28 EPS change or 56.00% from last quarter’s $0.5 EPS. HZNP’s profit would be $36.06M giving it 15.77 P/E if the $0.22 EPS is correct. After having $0.26 EPS previously, Horizon Pharma Public Limited Company’s analysts see -15.38% EPS growth. The stock decreased 0.07% or $0.01 during the last trading session, reaching $13.88. About 2.19M shares traded or 19.63% up from the average. Horizon Pharma Public Limited Company (NASDAQ:HZNP) has declined 28.13% since February 21, 2017 and is downtrending. It has underperformed by 44.83% the S&P500.

AMAZING ENERGY OIL &amp GAS CO (OTCMKTS:AMAZ) had a decrease of 68.33% in short interest. AMAZ’s SI was 1,900 shares in February as released by FINRA. Its down 68.33% from 6,000 shares previously. The stock increased 1.85% or $0.01 during the last trading session, reaching $0.55. About shares traded. Amazing Energy Oil and Gas, Co. (OTCMKTS:AMAZ) has 0.00% since February 21, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 13 analysts covering Horizon Pharma (NASDAQ:HZNP), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. Horizon Pharma had 55 analyst reports since September 9, 2015 according to SRatingsIntel. Mizuho maintained it with “Buy” rating and $30 target in Tuesday, November 8 report. The rating was maintained by UBS with “Buy” on Thursday, November 30. Mizuho maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) rating on Tuesday, May 10. Mizuho has “Buy” rating and $24 target. The stock has “Buy” rating by BMO Capital Markets on Monday, October 30. The rating was maintained by Mizuho on Monday, October 31 with “Buy”. The company was initiated on Tuesday, January 19 by Jefferies. The firm has “Buy” rating given on Tuesday, August 8 by Jefferies. Goldman Sachs initiated the shares of HZNP in report on Monday, June 6 with “Buy” rating. The company was maintained on Friday, November 10 by Cowen & Co. As per Monday, November 23, the company rating was reinitiated by Jefferies.

Horizon Pharma Public Limited Company, a biopharmaceutical company, engages in identifying, developing, acquiring, and commercializing medicines for the treatment of orphan diseases, arthritis, pain, and inflammation and inflammatory diseases in the United States and internationally. The company has market cap of $2.28 billion. The company's marketed medicine portfolio consists of ACTIMMUNE for the treatment of chronic granulomatous disease and malignant osteopetrosis; RAVICTI and BUPHENYL/AMMONAPS to treat urea cycle disorders; PROCYSBI for the treatment of nephropathic cystinosis; QUINSAIR for the treatment of chronic pulmonary infections due to pseudomonas aeruginosa in cystic fibrosis patients; and KRYSTEXXA to treat chronic refractory gout. It currently has negative earnings. The Company’s products also include RAYOS/LODOTRA for the treatment of rheumatoid arthritis, polymyalgia rheumatic, systemic lupus erythematosus, and multiple other indications; DUEXIS to treat signs and symptoms of osteoarthritis and rheumatoid arthritis; MIGERGOT for the treatment of vascular headache; PENNSAID 2% to treat pain of osteoarthritis of the knees; and VIMOVO for the treatment of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

Investors sentiment increased to 1 in 2017 Q3. Its up 0.08, from 0.92 in 2017Q2. It is positive, as 33 investors sold Horizon Pharma Public Limited Company shares while 50 reduced holdings. 28 funds opened positions while 55 raised stakes. 132.29 million shares or 1.03% more from 130.94 million shares in 2017Q2 were reported. 3.52M are held by Venbio Select Advisor Lc. Martingale Asset Mgmt L P has invested 0.02% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Etrade Capital Llc has 50,590 shares for 0.02% of their portfolio. Glenmede Comm Na reported 0.22% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). California State Teachers Retirement Sys holds 0.01% or 261,389 shares. Moreover, Great Lakes Advsrs Lc has 0.17% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 556,229 shares. Commonwealth Equity reported 16,013 shares stake. Renaissance Technologies Ltd Co reported 0.02% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP). California Employees Retirement Systems accumulated 325,085 shares. Guggenheim Ltd Llc owns 297,062 shares or 0.01% of their US portfolio. Chicago Equity Prns, a Illinois-based fund reported 136,120 shares. Qs Ltd owns 176,748 shares. North Carolina-based Financial Bank Of America De has invested 0.01% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). 194,105 were reported by Connor Clark Lunn Inv Management Ltd. Moreover, Royal State Bank Of Canada has 0% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP).

Amazing Energy Oil and Gas, Co., an independent energy company, engages in the acquisition, exploration, and development of gas and oil properties in Texas, the United States. The company has market cap of $37.34 million. The Company’s primary leasehold covers approximately 70,000 acres in Pecos County in the Permian Basin of West Texas. It currently has negative earnings. As of July 31, 2016, the companyÂ’s estimated net proved reserves were 745,190 barrels of oil equivalent.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>